On Invalid Date, Indivior (NASDAQ: INDV) reported Q1 2024 earnings per share (EPS) of $0.35, up 9.38% year over year. Total Indivior earnings for the quarter were $47.00 million. In the same quarter last year, Indivior's earnings per share (EPS) was $0.32.
As of Q2 2024, Indivior's earnings has grown year over year. Indivior's earnings in the past year totalled $5.00 million.
What was INDV's revenue last quarter?
On Invalid Date, Indivior (NASDAQ: INDV) reported Q1 2024 revenue of $284.00 million up 12.25% year over year. In the same quarter last year, Indivior's revenue was $253.00 million.
What was INDV's revenue growth in the past year?
As of Q2 2024, Indivior's revenue has grown 18.57% year over year. This is 8.43 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.14%. Indivior's revenue in the past year totalled $1.12 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.